A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : 5-MeO-DIPT / 5-methoxy-N,N-diisopropyltryptamine

[Related PubMed/MEDLINE]
Total Number of Papers: 27
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   5-MeO-DIPT  (>> Co-occurring Abbreviation)
Long Form:   5-methoxy-N,N-diisopropyltryptamine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 A Retrospective of Prevalence of Drugs of Abuse by Hair Analysis in Shanghai using LC-MS-MS. AFS, AMP, ATS, COC, LC-MS-MS, MA, MDA, MDMA, NK, THC
2020 Determination of 5-MeO-DIPT in Human Urine Using Gas Chromatography Coupled with High-Resolution Orbitrap Mass Spectrometry. 5-MeO-iPT, FWHM
2019 Application of hair analysis to document illegal 5-methoxy-N,N-dissopropyltrptamine (5-MeO-DiPT) use. LLOQ, LOD
2019 Effects of exposure to 5-MeO-DIPT during adolescence on brain neurotransmission and neurotoxicity in adult rats. DA
2018 The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats. NPS, PND, SPL
2018 The effect of repeated-intermittent exposure to 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT) during adolescence on learning and memory in adult rats. NPS, PND, SPL
2017 [A survey on high-risk behaviors and HIV infection among men having sex with men who use drugs in Tianjin in 2016]. MSM
2016 Recreational drug use and related social factors among HIV-positive men in Japan. ---
2015 The hallucinogenic world of tryptamines: an updated review. 5-MeODMT, AMT, DMT, LSD
10  2011 A quantitative method for simultaneous determination of 5-methoxy-N,N-diisopropyltryptamine and its metabolites in urine using liquid chromatography-electrospray ionization-tandem mass spectrometry. 5-MeO-iPT, 5-OH-DIPT
11  2011 Clinical toxicology of newer recreational drugs. BZP, CNS, DOB, LSD, MDMA
12  2010 Metabolism of designer drugs of abuse: an updated review. 3-MF, alpha-MF, MPBP, PCEEA, PCMEA, PCMPA, PVP
13  2009 Comparison of the developmental effects of 5-methoxy-N,N-diisopropyltryptamine (Foxy) to (+/-)-3,4-methylenedioxymethamphetamine (ecstasy) in rats. ---
14  2008 A general approach to the screening and confirmation of tryptamines and phenethylamines by mass spectral fragmentation. 3,4-MDA, 3,4-MDMA, 5-MeO-AMT, 5-MeODMT, AMT, DBT, DET, DiPT, DMT, DPT, MAMP
15  2008 Comparison of the separation of nine tryptamine standards based on gas chromatography, high performance liquid chromatography and capillary electrophoresis methods. 5-MeO-AMT, 5-MeODMT, AMT, DBT, DET, DiPT, DMT, DPT
16  2008 The roles of amino acid residues at positions 216 and 219 in the structural stability and metabolic functions of rat cytochrome P450 2D1 and 2D2. ---
17  2007 5-Methoxy-N,N-diisopropyltryptamine (Foxy), a selective and high affinity inhibitor of serotonin transporter. DAT, SERT
18  2007 The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. 3CPP, 5-MeO-AMT, 5-MeO-MIPT, 5-MeODMT, AMT, BDB, DPT, MBDB, TMA-2, TMA-6
19  2006 A fatal poisoning with 5-methoxy-N,N-diisopropyltryptamine, Foxy. 5-MeO-NIPT, 5-OH-DIPT
20  2006 Hallucinogen-like actions of 5-methoxy-N,N-diisopropyltryptamine in mice and rats. LSD, N,N-DMT
21  2006 [Analysis of the chemical drugs among structural isomer]. 4HO-DET, 4HO-MIPT, 4HO-MPT, 5MeO-DPT, AMT
22  2005 Sensitive determination of alpha-methyltryptamine (AMT) and 5-methoxy-N,N-diisopropyltryptamine (5MeO-DIPT) in whole blood and urine using gas chromatography-mass spectrometry. AMT, GC-MS, MDL
23  2004 A general screening and confirmation approach to the analysis of designer tryptamines and phenethylamines in blood and urine using GC-EI-MS and HPLC-electrospray-MS. 5-MeO-DiPT-N-oxide, 5-MeO-iPT, AMT, DMT, DPT, LC-MS, SIM
24  2004 Analytical chemistry of synthetic routes to psychoactive tryptamines. Part I. Characterisation of the Speeter and Anthony synthetic route to 5-methoxy-N,N-diisopropyltryptamine using ESI-MS-MS and ESI-TOF-MS. ---
25  2004 Schedules of controlled substances: placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into schedule I of the Controlled Substances Act. Final rule. AMT, CSA, DEA, DHHS
26  2003 Schedules of controlled substances: temporary placement of alpha-methyltryptamine and 5-methoxy-N,N-diisopropyltryptamine into Schedule I. Final rule. AMT, CSA, DEA
27  1980 N, N-Diisopropyltryptamine (DIPT) and 5-methoxy-N,N-diisopropyltryptamine (5-MeO-DIPT). Two orally active tryptamine analogs with CNS activity. DiPT